Dr. Burton is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2300 Childrens Plaza
Chicago, IL 60614Phone+1 773-880-4462Fax+1 773-929-9565
Education & Training
- McGaw Medical Center of Northwestern UniversityResidency, Pediatrics, 1973 - 1975
- Northwestern University The Feinberg School of MedicineClass of 1973
Certifications & Licensure
- IL State Medical License 1975 - 2026
- NC State Medical License 1977 - 1990
- American Board of Medical Genetics and Genomics Clinical Biochemical Genetics
- American Board of Medical Genetics and Genomics Clinical Genetics
- American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
- Top MD Consumers Checkbook
Clinical Trials
- Human Heterologous Liver Cells for Infusion in Children With Urea Cycle Disorders Start of enrollment: 2010 Dec 01
- An Open-Label Phase 3 Study of BMN 165 for Adults With PKU Not Previously Treated w/ BMN 165 Start of enrollment: 2013 May 01
- A Study of UX007 (Triheptanoin) in Participants With Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) Start of enrollment: 2014 Feb 06
- Join now to see all
Publications & Presentations
PubMed
- Genotype-phenotype findings in patients with mucopolysaccharidosis II from the Hunter Outcome Survey.Joseph Muenzer, Hernan Amartino, Barbara K Burton, Maurizio Scarpa, Anna Tylki-Szymańska
Molecular Genetics and Metabolism. 2024-09-10 - 3 citationsPegvaliase for the treatment of phenylketonuria: Final results of a long-term phase 3 clinical trial program.Cary O Harding, Nicola Longo, Hope Northrup, Stephanie Sacharow, Rani Singh
Molecular Genetics and Metabolism Reports. 2024-06-01 - 5 citationsEvaluating change in diet with pegvaliase treatment in adults with phenylketonuria: Analysis of phase 3 clinical trial data.Fran Rohr, Barbara Burton, Anne Dee, Cary O Harding, Joshua Lilienstein
Molecular Genetics and Metabolism. 2024-03-01
Journal Articles
- TANGO2: Expanding the Clinical Phenotype and Spectrum of Pathogenic VariantsJennifer N Dines, Heather C Mefford, Barbara Burton, Joline Dalton, Alice Basinger, Peter Karachunski, Can Ficicioglu, Katherine L Helbig, Nature
Press Mentions
- ‘We Have a Healthy Child:’ Eau Claire Couple Says Their Son Is Living Proof of the Need for Rare Disease ScreeningFebruary 16th, 2020
- ‘What’s Wrong with My Son?’ Wisconsin Rejects $4 Test for Rare, Terminal DiseaseJanuary 22nd, 2020
- 10 Years After Law Passed, Illinois Finally Ready to Test Newborns for Devastating DiseaseDecember 1st, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: